one
common
cancer
worldwid
oral
squamou
cell
carcinoma
oscc
associ
signific
death
rate
link
sever
risk
factor
notabl
failur
detect
neoplasm
earli
stage
repres
fundament
barrier
improv
surviv
qualiti
life
oscc
patient
present
studi
serum
sampl
oscc
patient
n
healthi
control
n
subject
twodimension
gel
electrophoresi
silver
stain
order
identifi
biomark
might
allow
earli
diagnosi
regard
spot
correspond
variou
upand
downregul
protein
sequenc
via
highresolut
malditof
mass
spectrometri
analyz
use
mascot
databas
identifi
follow
differenti
express
hostspecif
protein
within
sera
oscc
patient
leucinerich
lrg
abg
clusterin
clu
haptoglobin
hap
complement
proapolipoprotein
retinolbind
protein
precursor
moreov
five
nonhost
factor
detect
includ
bacteri
antigen
acinetobact
lwoffii
burkholderia
multivoran
myxococcu
xanthu
laribact
hongkongensi
streptococcu
salivariu
subsequ
analyz
immunogen
protein
use
pool
sera
oscc
patient
regard
five
candid
biomark
found
immunoreact
clu
hap
taken
togeth
immunoproteom
approach
identifi
variou
serum
biomark
could
facilit
develop
earli
diagnost
tool
oscc
oral
cancer
repres
sixth
preval
cancer
world
among
differ
type
oral
cancer
oral
squamou
cell
carcinoma
oscc
aris
oral
mucosa
account
malign
thu
oscc
common
malign
affect
head
neck
region
notabl
nearli
new
case
oral
cancer
report
annual
estim
approxim
oral
cancer
patient
die
worldwid
therefor
despit
recent
advanc
diagnosi
treatment
oral
cancer
eg
chemotherapi
radiotherapi
surgic
therapi
surviv
rate
oscc
patient
remain
less
fundament
barrier
improv
surviv
oscc
patient
fact
malign
often
remain
undetect
later
stage
regard
report
severalmonth
delay
diagnosi
could
reduc
chanc
surviv
thu
order
prevent
high
osccrel
mortal
rate
recent
attent
focus
identifi
potenti
diagnost
molecular
marker
eg
cell
cycl
regul
might
repres
biolog
predictor
oral
cancer
moreov
oscc
link
sever
risk
factor
includ
variou
bacteri
pathogen
might
use
detect
oscc
recent
studi
indic
earli
diagnosi
lifestyl
modif
effect
treatment
prevent
twothird
osccrel
mortal
howev
current
avail
diagnost
method
allow
detect
oral
cancer
earli
stage
visual
malign
lesion
oral
caviti
differ
microscop
method
avail
make
use
variou
techniqu
includ
autofluoresc
chemiluminesc
dyebas
tissu
stain
howev
due
low
sensit
specif
diagnost
strategi
clinician
gener
use
biopsi
detect
oscc
nevertheless
success
diagnosi
tissu
biopsi
highli
depend
acquir
whole
complet
tissu
sampl
patient
examin
regard
biopsi
harvest
oral
cancer
patient
often
associ
soft
tissu
surround
cancer
tissu
addit
oral
cancer
frequent
involv
develop
multipl
primari
tumor
inde
occurr
second
primari
tumor
higher
per
year
oral
cancer
compar
malign
therefor
identif
suitabl
reliabl
oscc
biomark
essenti
achiev
earli
detect
treatment
reduc
mortal
rate
oscc
patient
respect
antibodybas
diagnost
test
recogn
specif
tumorassoci
antigen
cancer
sera
might
repres
valid
methodolog
proteom
analysi
allow
identif
quantif
protein
peptid
biolog
sampl
howev
approach
numer
posttransl
form
protein
regul
includ
regul
enzym
low
abund
protein
may
remain
undetect
thu
present
investig
employ
immunoproteom
approach
pool
human
antibodi
detect
hostspecif
respons
protein
oscc
patient
specif
use
wellcharacter
analyt
platform
combin
twodimension
gel
electrophoresi
mass
spectrometri
ms
identifi
biomark
unfraction
sera
oscc
patient
normal
control
immunoproteom
approach
use
identifi
antigen
target
immun
system
sera
diseas
progress
addit
immun
respons
known
involv
mechan
carcinogenesi
therefor
compar
analys
reveal
distinct
oscc
biomark
might
promot
develop
specif
diagnost
test
earli
detect
oral
cancer
approv
consent
procedur
obtain
permiss
committe
clear
approv
record
studi
also
conduct
accord
intern
confer
harmonisationgood
clinic
practic
ichgcp
guidelin
declar
helsinki
perform
previous
describ
briefli
unfraction
human
serum
sampl
ml
lyse
rehydr
lysi
buffer
thiourea
urea
chap
dithreitol
pharmalyt
subject
isoelectr
focus
rehydr
precast
immobil
dri
strip
ph
ge
healthcar
sweden
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
perform
use
gradient
polyacrylamid
gel
presenc
sd
second
dimens
separ
gel
silver
stain
perform
previous
describ
silver
stain
coomassi
brilliant
blue
stain
ms
conduct
use
slightli
modifi
publish
method
imagescann
iii
ge
healthcar
sweden
use
captur
store
gel
imag
pdquest
gel
analysi
softwar
version
biorad
employ
evalu
differenti
express
protein
spot
ident
spot
match
serial
gel
normal
correct
spot
quantif
valu
geltogel
variat
unrel
express
chang
normal
method
use
total
densiti
gel
imag
ie
raw
quantiti
gel
spot
divid
total
quantiti
spot
within
gel
protein
concentr
valu
present
mean
percentag
volum
volum
standard
deviat
sd
student
ttest
oneway
analysi
varianc
anova
use
analyz
differ
patient
control
pvalu
less
consid
statist
signific
spot
interest
excis
subject
ingel
tryptic
digest
use
commerci
avail
kit
calbiochem
germani
ms
analysi
databas
search
perform
proteom
center
within
faculti
biolog
scienc
nation
univers
singapor
digest
peptid
mix
ml
chca
matrix
solut
mgml
acid
trifluoroacet
acid
tfa
acetonitril
acn
spot
onto
maldi
target
plate
abi
proteom
analyz
malditoftof
mass
spectromet
use
spectra
analysi
appli
biosystem
usa
mascot
search
engin
version
matrix
scienc
uk
employ
databas
search
addit
gp
explor
softwar
version
appli
biosystem
usa
util
along
mascot
identifi
peptid
protein
search
paramet
allow
ntermin
acetyl
ctermin
carbamidomethyl
cystein
fix
modif
methionin
oxid
variabl
modif
peptid
fragment
mass
toler
set
ppm
da
respect
peptid
mass
fingerprint
pmf
paramet
set
follow
one
miss
cleavag
allow
trypsin
digest
monoisotrop
mass
valu
da
peptid
mass
toler
peptid
charg
state
peptid
initi
identifi
use
proteinpilot
proteom
softwar
mass
spectromet
appli
biosystem
usa
score
reflect
relationship
theoret
experiment
determin
mass
calcul
assign
analys
conduct
use
intern
protein
index
http
wwwebiacukipi
ncbi
unigen
human
databas
version
total
entri
search
score
consid
signific
mascot
ncbi
databas
gel
immunoblot
protocol
organ
four
categori
normal
sera
probe
normal
sera
normal
sera
probe
oscc
sera
oscc
sera
probe
normal
sera
oscc
sera
probe
oscc
sera
run
gel
transfer
onto
nitrocellulos
membran
use
multiphor
ii
novablot
semidri
system
ge
healthcar
sweden
membran
block
superblock
pierc
usa
wash
three
time
trisbuff
salin
tb
membran
subsequ
incub
overnight
pool
sera
patient
healthi
subject
contain
primari
antibodi
variou
target
dilut
follow
wash
membran
incub
hour
room
temperatur
horseradish
peroxidas
hrp
link
monoclon
antihuman
immunoglobulin
igm
invitrogen
usa
membran
wash
visual
use
chemiluminesc
substrat
pierc
usa
cm
cm
film
kodak
usa
function
annot
analysi
perform
use
david
databas
annot
visual
integr
discoveri
provid
comprehens
set
function
annot
tool
understand
biolog
signific
associ
larg
list
gene
protein
function
categor
consid
signific
pvalu
less
obtain
string
search
tool
retriev
interact
gene
use
examin
proteinprotein
interact
network
imag
analysi
serum
protein
profil
healthi
subject
oscc
patient
unfraction
serum
sampl
separ
via
gener
highresolut
proteom
profil
healthi
subject
fig
oscc
patient
fig
protein
spot
gel
oscc
patient
n
normal
control
n
analyz
use
pdquest
gel
analysi
softwar
compar
analysi
reveal
sever
upand
downregul
protein
serum
oscc
patient
tabl
follow
digest
differenti
express
spot
ms
analysi
allow
us
identifi
follow
seven
hostspecif
protein
leucinerich
lrg
abg
clusterin
clu
haptoglobin
hap
proapolipoprotein
retinolbind
protein
precursor
tabl
furthermor
ms
analysi
reveal
complement
addit
hostspecif
protein
found
immunoreact
also
five
nonhost
factor
correspond
antigen
acinetobact
lwoffii
burkholderia
multivoran
myxococcu
xanthu
laribact
hongkongensi
streptococcu
salivariu
total
identifi
host
nonhost
specif
protein
spot
subsequ
subject
ms
analysi
malditof
tof
data
regard
identif
id
mascot
access
number
isoelectr
point
pi
molecular
mass
mr
protein
present
tabl
compar
candid
oscc
biomark
control
sampl
found
lrg
abg
clu
display
regul
respect
indic
clu
repres
significantli
decreas
protein
spot
notabl
downregul
factor
previous
studi
could
import
regard
oscc
lrg
protein
observ
patient
bacteri
infect
sever
acut
respiratori
syndrom
well
variou
malign
includ
pancreat
liver
lung
cancer
moreov
lrg
suggest
play
antiapoptot
role
stress
nevertheless
weivoda
et
al
report
low
level
lrg
patient
inflammatori
arthriti
spite
fact
lrg
produc
respons
inflamm
overal
relev
lrg
distinct
patient
group
remain
ill
defin
abg
one
eight
hostspecif
protein
observ
studi
interestingli
decreas
abg
express
also
observ
pancreat
cancer
hand
upregul
abg
previous
report
bladder
cancer
nonsmal
cell
lung
cancer
squamou
cell
carcinoma
uterin
cervix
regard
clu
differenti
express
link
oncogenesi
tumor
growth
bladder
breast
colorect
ovarian
pancreat
prostat
cancer
howev
although
mani
research
report
increas
clu
express
tumorigenesi
observ
significantli
downregul
clu
level
sera
oscc
patient
nevertheless
report
also
describ
similar
loss
clu
express
variou
tumor
includ
prostat
cancer
pancreat
cancer
esophag
squamou
cell
carcinoma
neuroblastoma
notabl
discrep
may
stem
fact
differenti
express
clu
isoform
human
tissu
fluid
may
exhibit
distinct
function
tumor
even
though
suggest
clu
regul
could
associ
diseas
progress
may
depend
type
cancer
notabl
true
function
clu
remain
elus
despit
extens
investig
far
clu
propos
particip
immedi
cellular
respons
stress
regul
cell
growth
surviv
regard
function
appear
isoform
depend
proapoptot
antiapoptot
form
final
analysi
reveal
ctermin
fragment
albumin
alb
downregul
protein
sera
oscc
patient
interestingli
kawakami
et
al
observ
also
regul
hepatocellular
carcinoma
patient
follow
cur
radiofrequ
ablat
contrast
jin
et
al
report
level
increas
cerebrospin
fluid
patient
syndrom
acut
inflammatori
autoimmun
disord
peripher
nervou
system
addit
downregul
protein
upregul
hostspecif
antigen
also
identifi
oscc
patient
includ
hap
compar
control
sampl
protein
display
increas
respect
found
upregul
notabl
correl
hap
express
malign
report
inde
similar
previou
studi
lai
et
al
found
hap
level
significantli
increas
sera
oscc
patient
furthermor
sinc
hap
primarili
hepatocyteproduc
rise
level
may
indic
occurr
acut
phase
respons
oscc
moreov
hap
also
report
particip
cell
migrat
extracellular
matrix
degrad
arteri
restructur
suggest
possibl
role
cancer
addit
hap
might
act
angiogen
agent
contribut
endotheli
cell
growth
differenti
regard
find
consist
studi
found
elev
express
variou
malign
includ
breast
colorect
nonsmal
cell
lung
pancreat
hepatocellular
cancer
possibl
increas
might
stem
reduc
activ
cleav
enzym
higher
turnov
also
observ
elev
level
oscc
suggest
express
cancer
cell
could
result
inhibit
kinas
activ
moreov
express
might
relat
retinoid
deplet
common
featur
cancer
patient
addit
level
influenc
transthyretin
could
reduc
renal
clearanc
addit
downand
upregul
selfantigen
also
identifi
five
nonhost
marker
proteom
profil
oscc
patient
protein
deriv
variou
bacteria
includ
lwoffii
b
multivoran
xanthu
l
hongkogenisi
salivariu
although
detect
factor
could
result
nosocomi
infect
heighten
risk
malign
link
virus
bacteria
schistosom
fact
relationship
bacteri
infect
cancer
discuss
decad
regard
sever
possibl
mechan
bacteria
could
oncogen
exampl
alter
host
respons
bacteri
infect
eg
chronic
inflamm
antigendriven
lymphoprolifer
hormon
induct
promot
epitheli
cell
prolifer
suggest
influenc
oncogenesi
also
bacteri
infect
lead
product
toxin
andor
carcinogen
metabolit
enhanc
oncogenesi
contrast
bacteri
infect
also
suggest
play
protect
role
alter
host
physiolog
reduc
cancer
risk
oral
cancer
consid
multifactori
diseas
stem
exposur
sever
type
carcinogen
includ
microbi
factor
inde
sever
piec
evid
support
associ
microbi
infect
oncogenesi
instanc
helicobact
pylori
link
gastric
cancer
categor
world
health
organ
intern
agenc
research
cancer
iarc
carcinogen
factor
human
similarli
chlamydophila
pneumonia
associ
malign
lymphoma
lung
cancer
male
wherea
candida
albican
streptococcu
anginosu
link
oral
carcinoma
also
demonstr
oscc
patient
possess
significantli
elev
concentr
certain
bacteria
saliva
thu
chang
salivari
microflora
could
repres
noninvas
diagnost
tool
predict
oral
cancer
immunoglobulin
igm
antibodi
present
circul
normal
human
mammalian
speci
igm
initi
secret
b
cell
upon
primari
antigen
stimul
particip
natur
defens
foreign
pathogen
well
neoplast
cell
tumor
fact
autoantibodi
specif
cancer
antigen
identifi
sever
type
tumor
includ
colon
breast
lung
ovari
prostat
head
neck
antibodi
found
recogn
sever
overexpress
eg
mutat
eg
tissuerestrict
eg
testiscanc
antigen
protein
produc
cancer
cell
elicit
immun
respons
therefor
detect
autoantibodi
patient
sera
could
exploit
mean
cancer
diagnosi
inde
specif
sensit
antibodi
respons
low
antigen
level
make
ideal
screeningdiagnost
tool
earli
identif
cancer
biomark
serumbas
assay
order
extend
result
obtain
immunoproteom
analys
perform
immunoblot
use
oscc
patient
control
sera
tabl
regard
perform
immunoblot
base
follow
four
condit
ie
categori
normal
pool
sera
probe
normal
pool
sera
normal
pool
sera
probe
oscc
pool
sera
oscc
pool
sera
probe
normal
pool
sera
oscc
pool
sera
probe
oscc
pool
sera
use
normal
pool
sera
normal
oscc
pool
sera
prove
reaction
restrict
tumor
specif
therefor
hostspecif
protein
could
detect
normal
control
base
result
could
detect
categori
fig
hap
show
immunogen
categori
blot
fig
detect
hap
categori
blot
reveal
support
role
natur
immun
cancer
cell
apart
involv
defens
system
pathogen
base
analysi
categori
fig
result
show
healthi
control
serum
autoantibodi
oscc
serum
antigen
clu
hostspecif
protein
show
immunoreact
immunoblot
aberr
hostspecif
protein
found
immunoreact
oscc
sera
compar
normal
sera
addit
antigen
protein
spot
also
detect
categori
final
four
reactiv
protein
spot
observ
categori
correspond
hap
fig
therefor
identifi
protein
uniqu
produc
innat
immun
respons
cancer
cell
altogeth
five
hostspecif
protein
found
immunoreact
oscc
patient
clu
hap
base
analys
data
support
rational
use
hostspecif
protein
cancer
biomark
panel
earli
detect
diagnosi
oscc
function
annot
analysi
perform
eight
candid
hostspecif
biomark
use
david
http
davidabccncifcrfgov
tabl
analysi
biolog
process
reveal
hap
involv
homeostasi
inde
cancerrel
inflamm
consid
essenti
hallmark
cancer
due
tumorpromot
consequ
inflammatori
respons
thu
studi
aberr
homeostat
mechan
indic
exist
interact
cancer
cell
host
immun
cell
carcinogenesi
addit
function
annot
analys
reveal
hostspecif
protein
locat
within
extracellular
region
indic
protein
mediat
immunogen
reaction
cancer
cell
therefor
find
show
protein
could
play
import
role
immunogen
carcinogenesi
moreov
clu
hap
found
associ
proteinlipid
complex
respons
tabl
hostand
nonhost
specif
protein
immunoblot
antigen
protein
categori
host
specif
protein
nonhost
specif
protein
cholesterol
lipid
transport
regard
cholesterol
act
key
contributor
carcinogenesi
promot
cell
migrat
mediat
inflammatori
process
inde
lipoprotein
may
major
supplier
cholesterol
cancer
cell
via
receptormedi
mechan
therefor
alter
protein
could
alter
lipid
metabol
increas
risk
cancer
develop
progress
protein
interact
network
gener
use
string
http
stringdborg
databas
identifi
potenti
bind
partner
hostspecif
biomark
fig
interestingli
hostspecif
protein
could
link
ten
predict
function
partner
apob
cfh
cfi
lcat
ttr
moreov
kegg
pathway
analysi
perform
use
david
complement
coagul
cascad
well
peroxisom
proliferatoractiv
receptor
ppar
signal
pathway
could
link
identifi
hostspecif
protein
notabl
two
pathway
predict
play
import
role
cancer
biolog
total
four
protein
cfh
cfi
found
involv
complement
coagul
cascad
p
pathway
may
particip
homeostat
process
influenc
host
defens
respons
inde
complement
cascad
activ
earli
immun
respons
might
import
cancer
immunotherapi
evid
suggest
activ
complement
regul
promot
tumor
growth
activ
coagul
cascad
cancer
highlight
alter
homeostasi
contribut
tumorigenesi
inde
report
coagul
pathway
could
induc
angiogenesi
facilit
tumor
growth
metastasi
state
tabl
base
david
function
annot
analysi
homeostasi
could
correl
protein
hap
howev
report
hap
possibl
relat
process
hemostasi
furthermor
found
associ
ppar
signal
pathway
p
ppar
member
nuclear
hormon
superfamili
activ
fatti
acid
deriv
ppar
signal
pathway
regul
lipid
metabol
cell
prolifer
cell
differenti
also
report
involv
regul
cancer
cell
apoptosi
prolifer
differenti
ppar
signal
propos
modifi
tumor
growth
affect
angiogenesi
inflamm
immun
cell
function
tumor
cell
environ
thu
target
ppar
signal
pathway
could
repres
potenti
strategi
cancer
therapi
use
proteom
profil
abl
identifi
sever
differenti
express
hostspecif
protein
sera
oscc
patient
includ
lrg
abg
clu
hap
immunogen
five
protein
confirm
western
blot
analys
clu
hap
addit
five
nonhost
factor
detect
includ
protein
lwoffii
b
multivoran
xanthu
l
hongkogenisi
salivariu
previous
suggest
combin
proteom
serolog
approach
one
use
present
studi
reflect
numer
event
occur
vivo
simultan
due
fact
patient
serum
complex
consist
mani
protein
data
indic
immunoproteom
approach
could
promis
applic
biomark
discoveri
diseas
progress
studi
could
use
landmark
comprehens
studi
appli
individu
patient
serum
larger
sampl
size
use
method
identifi
distinct
serum
biomark
might
facilit
develop
earli
diagnost
tool
oscc
promot
understand
host
respons
occur
oscc
patient
